Migone T S, Lin J X, Cereseto A, Mulloy J C, O'Shea J J, Franchini G, Leonard W J
Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Science. 1995 Jul 7;269(5220):79-81. doi: 10.1126/science.7604283.
Human T cell lymphotropic virus I (HTLV-I) is the etiological agent for adult T cell leukemia and tropical spastic paraparesis (also termed HTLV-I-associated myelopathy). HTLV-I-infected peripheral blood T cells exhibit an initial phase of interleukin-2 (IL-2)-dependent growth; over time, by an unknown mechanism, the cells become IL-2-independent. Whereas the Jak kinases Jak1 and Jak3 and the signal transducer and activator of transcription proteins Stat3 and Stat5 are activated in normal T cells in response to IL-2, this signaling pathway was constitutively activated in HTLV-I-transformed cells. In HTLV-I-infected cord blood lymphocytes, the transition from IL-2-dependent to IL-2-independent growth correlated with the acquisition of a constitutively activated Jak-STAT pathway, which suggests that this pathway participates in HTLV-I-mediated T cell transformation.
人类嗜T细胞病毒I型(HTLV-I)是成人T细胞白血病和热带痉挛性截瘫(也称为HTLV-I相关脊髓病)的病原体。HTLV-I感染的外周血T细胞表现出白细胞介素-2(IL-2)依赖性生长的初始阶段;随着时间的推移,通过未知机制,细胞变为IL-2非依赖性。虽然Jak激酶Jak1和Jak3以及信号转导和转录激活蛋白Stat3和Stat5在正常T细胞中响应IL-2而被激活,但该信号通路在HTLV-I转化的细胞中持续激活。在HTLV-I感染的脐血淋巴细胞中,从IL-2依赖性生长到IL-2非依赖性生长的转变与获得持续激活的Jak-STAT通路相关,这表明该通路参与HTLV-I介导的T细胞转化。